TOBIN JAMES R sold 6.8% of their position (15.04K shares) of TRANSMEDICS GROUP, INC. on the open market
Open‑market sale worth $1.60M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 5/3/2024ACC: 0000950170-24-052972
-15.04K
Net shares
Net seller
$1.60M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
15.04K disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−11.24K
Price / share
$105.70
Trade value
$1.19M
% of position
5.1%
5/1/2024
220.21K→208.97K
Common Stock
Indirect
Shares
−1.70K
Price / share
$106.89
Trade value
$182.14K
% of position
0.8%
5/1/2024
208.97K→207.27K
Common Stock
Indirect
Shares
−100.00
Price / share
$108.47
Trade value
$10.85K
% of position
0.0%
5/1/2024
207.27K→207.17K
Common Stock
Indirect
Shares
−2K
Price / share
$110.00
Trade value
$220K
% of position
1.0%
5/1/2024
207.17K→205.17K
Total
Net shares
−15.04K
Net value
-$1.60M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/1/2024 | S · Sale | −11.24K | $105.70 | $1.19M | 5.1% | 220.21K | 208.97K |
| Common Stock Indirect | 5/1/2024 | S · Sale | −1.70K | $106.89 | $182.14K | 0.8% | 208.97K | 207.27K |
| Common Stock Indirect | 5/1/2024 | S · Sale | −100.00 | $108.47 | $10.85K | 0.0% | 207.27K | 207.17K |
| Common Stock Indirect | 5/1/2024 | S · Sale | −2K | $110.00 | $220K | 1.0% | 207.17K | 205.17K |
| Total | −15.04K | -$1.60M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned1.19K
Total
1.19K direct1.19K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.19K | Direct |
| Total | 1.19K | 1.19K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported